China has responded tit-for-tat against the EU’s decision to ban China from selling medical devices to EU governments, barring EU medical device producers from selling to Chinese government hospitals.
Investment in medtech faces challenges as regulatory compliance gaps and fragmented European rules make thorough due diligence essential for investors.
The sale of genetics-led consumer healthcare and biotech company 23andMe has taken an unexpected turn, with bidding reopened and its co-founder and former CEO Anne Wojcicki putting in a nearly $50 million higher offer than the previously confirmed buyer.
Hims & Hers health, an American health and wellness platform, has announced its agreement to acquire ZAVA, a UK-based European telehealth platform, as part of a “significant step” in its global expansion.
US-based biotech company Regeneron Pharmaceuticals intends to buy the assets of genetics-led consumer healthcare and biotech company 23andMe in a bankruptcy auction, both companies announced on Monday.
Nearly three-quarters of patients in Europe are willing to share their health data if it means receiving more personalised care, according to recent research from Johnson & Johnson MedTech.
Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
DCC, A Dublin-based and London Stock Exchange-listed sales, marketing and support services group, has announced it has entered into a definitive agreement to sell its healthcare division to HealthCo, an investment vehicle of funds managed by European private equity firm Investindustrial Advisors, for £1.05 billion (approximately €1.23 billion).
A few weeks ago, I went to check out four Korean medtech startups in central London demonstrating their innovative solutions amid the UK’s growing senior healthcare crisis. Each startup addressed a challenge in elderly care, including fall prevention (with prevention being called for more generally in the UK health system too), medication adherence, dementia diagnosis, and air quality monitoring.
Healthtech was the strongest sector for investment in the first quarter of 2025 in the UK, with startups receiving $1.8bn, according to an HSBC report.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
